September 29, 2025

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: A 51% Upside Potential with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out as a compelling investment opportunity within the biotechnology sector, particularly for those interested in the healthcare landscape. With its focus on central nervous..

Sanofi (SNY) Investor Outlook: Potential 35% Upside Amid Strong Dividend Yield

Sanofi (SNY), a major player in the global healthcare sector, is capturing investor attention with a compelling mix of potential stock growth and robust dividend yield. Headquartered in Paris, France,..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 30% Potential Upside Amidst Healthcare Sector Dynamics

Investors looking at Teva Pharmaceutical Industries (NYSE: TEVA) might find themselves intrigued by the company’s current positioning within the healthcare sector, particularly the drug manufacturing industry specializing in both specialty..

Exact Sciences Corporation (EXAS) Stock Analysis: Uncovering a 20.68% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) has been making waves in the healthcare diagnostics sector with its innovative cancer screening solutions. As a pioneering player in diagnostics and research, Exact Sciences..

Encompass Health Corporation (EHC) Stock Analysis: Strong Buy Ratings and 8.46% Potential Upside

Investors seeking opportunities in the healthcare sector may find Encompass Health Corporation (NYSE: EHC) an intriguing proposition. With a market capitalization of $12.76 billion, this Birmingham, Alabama-based company stands as..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 47.68% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leading player in the healthcare sector, specializes in medical instruments and supplies with a focus on orthodontic and dental solutions. The company’s innovative product..

Cardinal Health, Inc. (CAH) Stock Analysis: Healthcare Giant with a 17.61% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) has long been a stalwart in the healthcare sector, particularly within the medical distribution industry. With a market capitalization of $36.52 billion, the company is..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Robust Growth Trajectory in the Healthcare Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) is a prominent player in the diagnostics and research industry, with a strong foothold in the healthcare sector. Headquartered in Cincinnati, Ohio, Medpace offers a..

AstraZeneca PLC (AZN) Stock Analysis: A Strong Buy with an 18.45% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a heavyweight in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects. As a leading biopharmaceutical company based..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A 17.64% Potential Upside for Investors

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, stands as a formidable player in the diagnostics and research industry. With a market capitalization of $175.3 billion,..

Avantor, Inc. (AVTR) Stock Analysis: Exploring the 17.72% Potential Upside

Avantor, Inc. (NYSE: AVTR) has piqued the interest of investors with a promising potential upside of 17.72%, positioning itself as a noteworthy player in the healthcare sector. As a provider..

Walgreens Boots Alliance, Inc. (WBA) Investor Outlook: High Dividend Yield Amidst Mixed Financial Metrics

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a formidable player in the healthcare and pharmaceutical retail sectors, with operations spanning the United States, Europe, and beyond. For individual investors..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a Potential 20% Upside

IQVIA Holdings, Inc. (NYSE: IQV), a formidable player in the healthcare sector, specifically within the diagnostics and research industry, stands as a compelling consideration for investors eyeing the intersection of..

Pfizer Inc. (PFE) Stock Analysis: Exploring a 21.65% Potential Upside with Strong Dividend Yield

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to attract attention from investors seeking both growth potential and stable income. This U.S.-based pharmaceutical giant, with a market..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Healthcare Giant with Nearly 10% Upside Potential

Investors eyeing the healthcare sector might find IDEXX Laboratories, Inc. (NASDAQ: IDXX) an intriguing option, especially given its current market dynamics. Specializing in diagnostics and research, IDEXX Laboratories commands a..

ICON plc (ICLR) Stock Analysis: Unveiling a 31.67% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading player in the healthcare sector, holds a pivotal position in the diagnostics and research industry. Headquartered in Dublin, Ireland, this global clinical research organization..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Tightrope Between Growth and Valuation

For investors with a keen eye on the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing case. As a leading provider in the Diagnostics & Research industry, the..

BridgeBio Pharma (BBIO): Investor Outlook with a 32.50% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its promising pipeline of transformative medicines designed to treat genetic diseases and cancers. Based in Palo Alto,..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a 29.92% Potential Upside in Biotech

Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical company headquartered in Hellerup, Denmark, is making headlines in the biotechnology sector with its promising pipeline and robust market performance. With a market..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring the 12.62% Potential Upside in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) presents a compelling opportunity for investors with its noteworthy potential upside of 12.62%. As a key player in the healthcare sector, specifically within the diagnostics..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds